These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19093964)

  • 1. Genetic correlates of protection against HIV infection: the ally within.
    Piacentini L; Biasin M; Fenizia C; Clerici M
    J Intern Med; 2009 Jan; 265(1):110-24. PubMed ID: 19093964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic basis of HIV-1 infection, transmission and disease progression.
    Singh P; Kaur G; Sharma G; Mehra NK
    Vaccine; 2008 Jun; 26(24):2966-80. PubMed ID: 18321617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of HIV to AIDS: a protective role for HLA-B27?
    den Uyl D; van der Horst-Bruinsma IE; van Agtmael M
    AIDS Rev; 2004; 6(2):89-96. PubMed ID: 15332431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV/AIDS. HIV: experiencing the pressures of modern life.
    Nolan D; James I; Mallal S
    Science; 2005 Mar; 307(5714):1422-4. PubMed ID: 15746416
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].
    Zúñiga J; Vargas-Alarcón G; Salgado N; Flores C; Martínez-Tripp S; Miranda A; Balbuena A; Osnaya N; Juárez F; Granados J; Reyes-Terán G
    Rev Invest Clin; 2000; 52(3):284-95. PubMed ID: 10953612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
    Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
    AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of human natural resistance to HIV: a summary of ten years of research in the Colombian population.
    Rugeles MT; Velilla PA; Montoya CJ
    Biomedica; 2011 Jun; 31(2):269-80. PubMed ID: 22159545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
    Zapata W; Montoya CJ; Rugeles MT
    Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.
    Arenzana-Seisdedos F; Parmentier M
    Semin Immunol; 2006 Dec; 18(6):387-403. PubMed ID: 16978874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantage of rare HLA supertype in HIV disease progression.
    Trachtenberg E; Korber B; Sollars C; Kepler TB; Hraber PT; Hayes E; Funkhouser R; Fugate M; Theiler J; Hsu YS; Kunstman K; Wu S; Phair J; Erlich H; Wolinsky S
    Nat Med; 2003 Jul; 9(7):928-35. PubMed ID: 12819779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of the HIV-1 protective Delta ccr5 allele in most ethnic populations of India.
    Majumder PP; Dey B
    Eur J Hum Genet; 2001 Oct; 9(10):794-6. PubMed ID: 11781692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
    Hirbod T; Broliden K
    J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and immune correlates of the HIV infection and vaccine-induced immunity. Foreword.
    Füst G
    Vaccine; 2008 Jun; 26(24):2949-50. PubMed ID: 18321613
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of human leukocyte antigen E and G in HIV infection.
    Tripathi P; Agrawal S
    AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
    [No Abstract]   [Full Text] [Related]  

  • 18. Elite controllers as a model of functional cure.
    Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
    Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
    Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
    AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of HIV-1 resistance and susceptibility: an approach to understand correlation between human genes and HIV-1 infection.
    Kumar V; Prakash O; Manpreet S; Sumedh G; Medhi B
    Indian J Exp Biol; 2006 Sep; 44(9):683-92. PubMed ID: 16999022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.